Skip to content

Effectiveness of 'Haozhensuci' acupuncture therapy for the third lumbar transverse process syndrome: a randomized controlled trial

Effectiveness of 'Haozhensuci' acupuncture therapy for the third lumbar transverse process syndrome: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16010165
Enrollment
Unknown
Registered
2016-12-15
Start date
2015-10-09
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Third Lumbar Trans-verse Process Syndrome

Interventions

A:ordinary acupuncture
B:Hao Zhen Su Ci

Sponsors

Lianyungang Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for the third lumbar transverse process syndrome; 2. Aged 20-70 years male and female; 3. not receiving any other acupuncture treatment or clinic trail; 4. Third lumbar transverse process syndrome was diagnosed by X-rays,CT or MR; 5. Written and informed consent.

Exclusion criteria

Exclusion criteria: 1. Do not accord with standard of the diagnosis of the third lumbar transverse process syndrome; 2. pregnant and lactating women; 3. with cardiovascular, cerebrovascular, Autoimmune diseases, liver and kidney function is not complete, and other seriousdisease or mental illness; 4. with lumbar fractures,spinal bone tumor, tuberculosis, osteoporosis and other patients; 5. Congenital Spine Malformations or scoliosis; 6. reluctant to join the trials.

Design outcomes

Primary

MeasureTime frame
The McGill Pain Questionnaire;

Secondary

MeasureTime frame
Clinical signs questionnaire of Low back pain;adverse reactions of acupuncture;

Countries

China

Contacts

Public ContactHuang Qian

Lianyungang Hospital of Traditional Chinese Medicine

761603236@qq.com+86 18705135858

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026